As of 2024-12-11, the Fair Value of 10X Genomics Inc (TXG) is -7.54 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 16.15 USD, the upside of 10X Genomics Inc is -146.69%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -31.30 | -542.70 | -58.20 | -166.00 | -255.10 | -210.66 |
| YoY growth | 72.18% | -1,633.87% | 89.28% | -185.22% | -53.67% | -342.26% |
| Market Cap (mil) | 1,954.96 |
| P/E | |
| Forward P/E |
| EPS | -1.51 |
| Avg earnings growth rate | -342.26% |
| TTM earnings | -182.55 |